Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
about
A simple method to quantitate IP-10 in dried blood and plasma spotsNovel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells.Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic areaMycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated populationDifferential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from HondurasIncreased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assayDiverse cytokine profile from mesenteric lymph node cells of cull cows severely affected with Johne's disease.Immunodiagnosis of tuberculosis: a dynamic view of biomarker discoveryPost-treatment change in Mycobacterium tuberculosis antigen-stimulated tumor necrosis factor-alpha release in patients with active tuberculosisSimian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation.Gene expression profiling identifies candidate biomarkers for active and latent tuberculosisPotential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosisImmune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising markerCombined Expression of IFN-γ, IL-17, and IL-4 mRNA by Recall PBMCs Moderately Discriminates Active Tuberculosis from Latent Mycobacterium tuberculosis Infection in Patients with Miscellaneous Inflammatory Underlying ConditionsIdentification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.Immunological biomarkers of tuberculosis.Liposomes as drug delivery systems for the treatment of TB.Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.Protection versus pathology in tuberculosis: recent insights.Biomarkers of tuberculosis: a research roadmap.Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.Inflammation and tuberculosis: host-directed therapies.T cells and adaptive immunity to Mycobacterium tuberculosis in humans.Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients.A possible complementary tool for diagnosing tuberculosis: a feasibility test of immunohistochemical markers.Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa.Characterization of a novel antigen of Mycobacterium tuberculosis K strain and its use in immunodiagnosis of tuberculosis.Molecular cloning, expression, and in silico structural analysis of guinea pig IL-17.ORFeome-based identification of biomarkers for serodiagnosis of Mycobacterium tuberculosis latent infection.Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
P2860
Q28727912-EF143B27-1556-4E84-8F34-9975CAD1C0CEQ34014562-5E650189-836A-4500-A8B4-AC94D34158D9Q34302593-1483FD92-9A5B-4571-B8BF-7A5D67DA3F96Q34478705-D8FE111E-180D-42ED-8E07-4DF1DC096D49Q34525238-5120B204-C1DC-4A82-9AA8-FEF3F66A071AQ34623344-2C514CAB-28BC-4937-850E-ACC70C91B3CEQ34693098-75FEE275-DD28-42FC-A483-CEEA760E9CC2Q34731357-D4F3150D-BE3E-49D9-B19D-74C9763DB2FEQ34790516-11CC0B04-AFD6-4955-A983-BB7F78B775F1Q34949342-B7F2C988-9DA4-41F0-8E88-AA5D280A4FEAQ35191190-2E582BB4-1FFA-4AE0-9B45-8C00983F4FF2Q35361654-BA52576D-243C-4EC2-9190-5D1A9E612411Q35681015-D259F4DC-A5B1-4D24-AD81-4885BEE52ED6Q35851673-586B2FBB-66F0-46D3-AFE9-72B8D3CC7478Q35906290-651895CC-E4B9-4485-8888-D1C3627D51E8Q36235513-5CF4CF6D-160D-4130-A5A2-4DF47136EFB6Q36362277-E9F313C2-58DF-4975-8592-9D118082B91CQ36384603-709E2789-AE63-4E63-9C74-A3BDBAA25259Q36999711-DD810A3E-3AA6-4F4C-88AB-4B48ED786292Q37545011-4FA78598-B95F-4335-98DB-3551D065E963Q37862987-B5D21AFC-D86E-4E3D-B215-F9B3B9C32C99Q37949386-99D0ABF3-E459-4FCD-B44A-6E346F9CE826Q37953955-E3BB6B82-2A07-4D07-84CA-4187B95B678AQ37988577-70508E6E-89AD-4E45-976D-C22210AA51C5Q38011865-EBBB56EE-E144-4F6B-BCA5-995E2C122EB3Q38111807-5A83C860-51F3-4DA5-8AEA-E09A518124EAQ38167718-E7DCF896-60AC-4D91-BCE5-5648C09606DBQ38203352-1D1BABD0-8F29-43DD-961B-B8EF7CD4AAFEQ38363792-F5D6938F-D5BD-431F-8FF3-38900C9B3112Q38620366-CD23F8DB-B2D6-47D6-A71D-C2C38EDC6AF7Q39524649-465161D9-5DC5-4D7B-89F2-695DD54958D0Q40044975-203268E8-7461-4D69-8E37-DDA298F91879Q41601094-D19AAC89-9A32-4FBF-AF3C-749943D09250Q41920055-F047FA11-7184-4B24-AD5B-6FDFCCECBDFBQ42197251-BBD96CA5-5921-455E-86B3-6A1FF91137E8Q42256906-B7588C00-3CB0-4685-BDE7-595C55857FE8Q47150163-6915E445-BB15-46D6-B803-A0D4A18639B1Q54255391-D0C29410-65C0-4723-9B3C-8E04BE0705F0
P2860
Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@ast
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@en
type
label
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@ast
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@en
prefLabel
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@ast
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@en
P2093
P2860
P1433
P1476
Production of TNF-alpha, IL-12 ...... tion in a West African cohort.
@en
P2093
David J Jeffries
Ifedayo M Adetifa
Martin O C Ota
P2860
P304
P356
10.1371/JOURNAL.PONE.0012365
P407
P577
2010-08-24T00:00:00Z